Atidortoxumab Human Monoclonal Antibody
Atidortoxumabis a research-grade recombinant antibody targeting Alpha-hemolysin. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Alpha-hemolysin, hly, Alpha-HL, Alpha-toxin, hla
UniProt
P09616
Reactivity
Bacteria
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-34316R-RBITC-TR 20 µL
AIF Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details 
MBS6313071-01 0.2 mL
KHDRBS3, NT (KHDRBS3, SALP, SLM2, KH domain-containing, RNA-binding, signal transduction-associated protein 3, RNA-binding protein T-Star, Sam68-like mammalian protein 2, Sam68-like phosphotyrosine protein) (PE)
Sign In for Pricing
View Details MBS6313071-02 5x 0.2 mL
KHDRBS3, NT (KHDRBS3, SALP, SLM2, KH domain-containing, RNA-binding, signal transduction-associated protein 3, RNA-binding protein T-Star, Sam68-like mammalian protein 2, Sam68-like phosphotyrosine protein) (PE)
Sign In for Pricing
View Details 
10-847 0.1 mg
Gimsilumab (CSF2 /GM-CSF) - Research Grade Biosimilar
Sign In for Pricing
View Details